RFK Jr. remains firmly entrenched as HHS Secretary with active leadership moves, including recent elevations of senior advisors to advance the administration’s health agenda and a scheduled keynote at the Children’s Health Defense conference. President Trump’s continued backing and the absence of resignation signals or Senate pressure sustain trader expectations that he will serve through year-end. Ongoing legal challenges over vaccine advisory appointments and public health controversies, such as measles outbreaks, have not translated into removal momentum. With midterms approaching and internal reorganization underway, the 79% implied probability for “No” reflects consensus that structural and political barriers to departure outweigh short-term risks before December 31.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · Aggiornato$24,819 Vol.
$24,819 Vol.
$24,819 Vol.
$24,819 Vol.
An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Mercato aperto: Mar 19, 2026, 2:02 PM ET
Risolutore
0x65070BE91...An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Risolutore
0x65070BE91...RFK Jr. remains firmly entrenched as HHS Secretary with active leadership moves, including recent elevations of senior advisors to advance the administration’s health agenda and a scheduled keynote at the Children’s Health Defense conference. President Trump’s continued backing and the absence of resignation signals or Senate pressure sustain trader expectations that he will serve through year-end. Ongoing legal challenges over vaccine advisory appointments and public health controversies, such as measles outbreaks, have not translated into removal momentum. With midterms approaching and internal reorganization underway, the 79% implied probability for “No” reflects consensus that structural and political barriers to departure outweigh short-term risks before December 31.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · Aggiornato


Fai attenzione ai link esterni.
Fai attenzione ai link esterni.
Domande frequenti